Penumbra Inc.
Clinical trials sponsored by Penumbra Inc., explained in plain language.
Penumbra Inc.
PEN
NYSE
A medical device company focused on neurovascular and peripheral vascular therapies.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New device aims to suck out deadly lung clots in major trial Results expected Dec 2026 (estimated)